173 related articles for article (PubMed ID: 3516514)
21. Aspiration cytology of neoplastic and non-neoplastic ovarian cysts: is it accurate?
Ganjei P; Dickinson B; Harrison T; Nassiri M; Lu Y
Int J Gynecol Pathol; 1996 Apr; 15(2):94-101. PubMed ID: 8786211
[TBL] [Abstract][Full Text] [Related]
22. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.
Wu H; Yan LN; Cheng NS; Zhang YG; Ker CG
Hepatogastroenterology; 2007; 54(79):1915-8. PubMed ID: 18251127
[TBL] [Abstract][Full Text] [Related]
23. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
Tang BJ; Li L; Xu J
Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406
[TBL] [Abstract][Full Text] [Related]
24. Blood group substance, CEA, and lectins in ovarian tumors.
Dietel M; Arps H; Hölzel F; Viale G; Dell'Orto P; Kröger A; Niendorf A
Cancer Detect Prev; 1986; 9(5-6):511-20. PubMed ID: 3465441
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary].
Kizawa I; Kikuchi Y; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):251-8. PubMed ID: 6833810
[TBL] [Abstract][Full Text] [Related]
26. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
27. Giant ovarian cyst in a dwarf.
Semchyshyn S; Strickler RC; Gerulath AH
Can J Surg; 1977 Mar; 20(2):153-5. PubMed ID: 844002
[TBL] [Abstract][Full Text] [Related]
28. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
Wahlberg K; Høyer-Hansen G; Casslén B
Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
[TBL] [Abstract][Full Text] [Related]
29. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
Ott HW; Lindner H; Sarg B; Mueller-Holzner E; Abendstein B; Bergant A; Fessler S; Schwaerzler P; Zeimet A; Marth C; Illmensee K
Cancer Res; 2003 Nov; 63(21):7507-14. PubMed ID: 14612552
[TBL] [Abstract][Full Text] [Related]
30. [Distribution of lectin-receptors in ovarian cystadenoma and cystadenocarcinoma].
Hu NP
Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):40-2. PubMed ID: 2776253
[TBL] [Abstract][Full Text] [Related]
31. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
32. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):67-70. PubMed ID: 16359773
[TBL] [Abstract][Full Text] [Related]
33. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
[TBL] [Abstract][Full Text] [Related]
34. Cystadenoma and cystadenocarcinoma of the liver: localization of carcinoembryonic antigen.
Tomioka T; Tsuchiya R; Harada N; Tsunoda T; Matsuo T
Jpn J Surg; 1986 Jan; 16(1):62-7. PubMed ID: 3515006
[TBL] [Abstract][Full Text] [Related]
35. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
36. Aspiration cytology and E2 content in ovarian tumors.
Geier GR; Strecker JR
Acta Cytol; 1981; 25(4):400-6. PubMed ID: 6945006
[TBL] [Abstract][Full Text] [Related]
37. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses.
Lu D; Davila RM; Pinto KR; Lu DW
Diagn Cytopathol; 2004 May; 30(5):320-4. PubMed ID: 15108229
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
[TBL] [Abstract][Full Text] [Related]
39. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
[TBL] [Abstract][Full Text] [Related]
40. [The present status of tumor markers in malignant ovarian tumor].
Nishimura H; Miyoshi T; Hamai J; Miyahara K
Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
